References
- Brechmann T, Günther K, Neid M, et al. Triggers of histologically suspected drug-induced colitis. World J Gastroenterol. 2019;25:967–979.
- Pusztaszeri MP, Genta RM, Cryer BL. Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations. Nat Rev Gastroenterol Hepatol. 2007;4:442–453.
- Grattagliano I, Ubaldi E, Portincasa P. Drug-induced enterocolitis: prevention and management in primary care. J Dig Dis. 2018;19:127–135.
- Sherid M, Ehrenpreis ED. Types of colitis based on histology. Dis Mon. 2011;57:457–489.
- Price AB. Pathology of drug-associated gastrointestinal disease. Br J Clin Pharmacol. 2003;56:477–482.
- Puspok A, Kiener HP, Oberhuber H. Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum. 2000;43:658–691.
- Hsu S-C, Chang S-S, Lee M-t. G, et al. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: an analysis of nationally representative cohort. PLoS One. 2017;12:e0183813.
- Abdalla S, Brouquet A, Lazure T, et al. Outcome of emergency surgery for severe neuroleptic-induced colitis: results of a prospective cohort. Colorectal Dis. 2016;18:1179–1185.
- Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99:1175–1190.
- McCarthy AJ, Lauwers GY, Sheahan K. Iatrogenic pathology of the intestines. Histopathology. 2015;66:15–28.
- McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:e1–e48.
- Crobach MJ, Planche T, Eckert C, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22:63–81.
- Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut. 2004;53:346–350.
- Cotter TG, Pardi DS. Current approach to the evaluation and management of microscopic colitis. Curr Gastroenterol Rep. 2017;9:1–6.
- Higgins PD, Davis KJ, Laine L. Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther. 2004;19:729–738.
- Menees SB, Powell C, Kurlander J, et al. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol. 2015;110:444–454.
- Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949–958.
- Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376:2566–2578.
- Foell D, Wittkowski H, Roth J. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut. 2009;58:859–868.
- Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology. 2015;149:1275–1285.
- Young J, Badgery-Parker T, Dobbins T, et al. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status. J Pain Symptom Manage. 2015;49:258–264.
- Davis P, Hayden J, Springer J, et al. Prognostic factors for morbidity and mortality in elderly patients undergoing acute gastrointestinal surgery: a systematic review. Can J Surg. 2014;57:E44–52.
- Jessurun J. The differential diagnosis of acute colitis: clues to a specific diagnosis. Surg Pathol Clin. 2017;10:863–885.